Afficher la notice abrégée

dc.contributor.authorAcebedo-Martínez, Francisco J.
dc.contributor.authorAlarcón Payer, Carolina
dc.contributor.authorDomínguez Martín, Alicia 
dc.contributor.authorFrontera, Antonio
dc.contributor.authorProhens, Rafel
dc.contributor.authorBarbas, Rafael
dc.contributor.authorChoquesillo Lazarte, Duane
dc.date.accessioned2025-10-26T06:32:55Z
dc.date.available2025-10-26T06:32:55Z
dc.date.issued2025-10-07
dc.identifier.citationAcebedo-Martínez, F. J., Alarcón-Payer, C., Domínguez-Martín, A., Frontera, A., Prohens, R., Barbas, R., & Choquesillo-Lazarte, D. (2025). Exploring sublimation as a tool for polymorphic screening in niflumic acid–caffeine pharmaceutical cocrystals. Crystal Growth & Design, acs.cgd.5c01007. https://doi.org/10.1021/acs.cgd.5c01007es_ES
dc.identifier.urihttps://hdl.handle.net/10481/107439
dc.description.abstractSublimation has emerged as a powerful tool for polymorphic screening in pharmaceutical multicomponent materials. In this work, a combined strategy involving mechanochemistry and sublimation enables the selective synthesis and isolation of a novel polymorph (Form III) of the niflumic acid−caffeine (NIF− CAF) cocrystal. Solid-state characterization and complementary theoretical studies revealed that Form III is morphotropically related to Form II, sharing a similar molecular conformation with the −COOH and −CF3 groups positioned on the same side of the NIF molecule. However, Form III exhibits a distinct packing arrangement, featuring embedded −CF3 groups and alternating molecular tapes stabilized by π−π and F···F interactions. Thermal analysis also indicates an enantiotropic relationship between Forms II and III, with Form III becoming the more stable phase above the estimated transition temperature of ∼102 °C, and showing a melting point of 156 °C. These findings demonstrate the relevance of sublimation in polymorphic screening and its potential to expand the solid-state landscape of multicomponent materials with enhanced control and reproducibilityes_ES
dc.description.sponsorshipMCIU/AEI/10.13039/501100011033 and ERDF – (Grants PID2023-151538NB-I00, PID2023-146632OB-I00, PID2023-148453NB-I00)es_ES
dc.language.isoenges_ES
dc.publisherAmerican Chemical Societyes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleExploring Sublimation as a Tool for Polymorphic Screening in Niflumic Acid−Caffeine Pharmaceutical Cocrystalses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1021/acs.cgd.5c01007
dc.type.hasVersionVoRes_ES


Fichier(s) constituant ce document

[PDF]

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Atribución 4.0 Internacional
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Atribución 4.0 Internacional